雖然這篇pioneer-hf trial ppt鄉民發文沒有被收入到精華區:在pioneer-hf trial ppt這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]pioneer-hf trial ppt是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Angiotensin–Neprilysin Inhibition in Acute Decompensated ...
The PIONEER-HF trial was performed to evaluate the use of a neprilysin inhibitor added to a renin–angiotensin system inhibitor, as compared with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2Pioneer hf - SlideShare
Pioneer HF trial in patients with Acute decompensated heart failure started on angiotensin receptor neprilysin inhibitor.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3PIONEER-HF.pdf
Hospitalized With Acute Decompensated Heart Failure ... PARADIGM-HF trial in chronic HFrEF: sacubitril/valsartan → ... NEJM. 2014;371:993-1004.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4PIONEER-HF
Trial description: Patients hospitalized with acute decompensated heart failure (ADHF) were randomized in a 1:1 fashion to either sacubitril/valsartan or ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5sacubitril/valsartan N = 440 9.3% enalapril N = 441 - CRTonline
PARADIGM-HF trial in chronic HFrEF: sacubitril/valsartan ... NEJM. 2014;371:993-1004. 4. Study Design. sacubitril/valsartan. enalapril.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Sacubitril-valsartan (Entresto)
Clinical Trials. Trial Name. Date Published. Patient Population. PARADIGM-HF. 9/11/2014. Heart Failure with Reduced Ejection (HFrEF). PIONEER-HF. 11/11/2018.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7Clinical outcomes in patients with acute decompensated heart
PIONEER -HF was an 8-week multicenter, randomized, double-blind, double-dummy, active-controlled trial of in-hospital initiation of sacubitril/ ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8pioneer-hf trial findings and significance - American Heart ...
Heart failure (HF) is a major public health problem ... morbidity in Heart Failure trial (PARADIGM-HF) ... NEJM. 2014;371:993-1004.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9CCS/CHFS 2021 Heart Failure Guidelines Update - Canadian ...
Avoid use of CCS logos or trademarks on slides, tools or publications that are ... PIONEER-HF (and extension study), Sac-val vs Enalapril ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in ...
PIONEER Trial : Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure · REGISTER for free or ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11Clinical outcomes of Sacubitril/Valsartan in patients with acute ...
The PIONEER-HF trial (Comparison of Sacubitril/Valsartan versus Enalapril on Effect on NT-pro BNP [N-terminal pro-B type natriuretic ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12Neprilysin Inhibition 5 Years After PARADIGM-HF | JACC
由 KF Docherty 著作 · 2020 · 被引用 20 次 — In 2014, the PARADIGM-HF trial (Prospective Comparison of ARNI with ACEI to ... in the PIONEER-HF (Comparison of Sacubitril-Valsartan versus Enalapril on ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Clinical Trial and Biomarker Data - Entresto HCP
Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF trial. Circulation ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Sacubitril/valsartan for the management of heart failure
Additional clinical trial data are required to confirm the ... The PIONEER-HF study investigated the safety of S/V (target dose of 97 mg of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15Rationale and design of TRANSITION: a randomized trial of ...
PIONEER ‐HF compares in‐hospital initiation of sacubitril/valsartan vs. enalapril in patients who have been stabilized following hospitalization for ADHF with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart ...
The PIONEER-HF trial was designed to compare the safety and efficacy of the sacubitril-valsartan combination with enalapril in patients who ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17NEW ERA FOR HEART FAILURE MANAGEMENT - HKCC ...
PARADIGM-HF STUDY. NEJM 2014;371:993-1004 ... Trial stopped early after recruiting 25% pts at medican FU 27 mths. Page 9. PIONEER-HF STUDY.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18PIONEER-HF - Wiki Journal Club
Published in 2019, the PIONEER-HF was a biomarker-endpoint trial that randomized 881 adults with ADHF and reduced EF to the ARNI ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19PIONEER-HF (TIMI 62)
PIONEER -HF was a multicenter, randomized, double-blind, double dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20Safe to Start Sacubitril/Valsartan Predischarge in Acute HF
In first of its kind data from the TRANSITION trial, patients safely ... That study, called PIONEER-HF, also has a placebo-control group and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21NEJM Landmark Trial Repository Prepared 2/12/2020 By
NEJM Landmark Trial Repository. Prepared 2/12/2020. By: Joshua A. Ronen, MD, Class of 2021 ... PIONEER-HF – ANRI in Acute Decompensated Heart Failure.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22Sacubitril/Valsartan Initiated in Black Patients Admitted for ...
The PIONEER-HF trial was a prospective, multicenter, double-blind, active-controlled, randomized trial which enrolled 881 pts at 129 sites ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23Diapositivas-Estudio-PARADIGM-HF-Trial-ppt-pptx
Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24Heart Failure 2019- The world has changed - RACP
Not heart failure preserved ejection fraction (HFpEF) ... PIONEER-HF: key points of study design ... NEJM 2008;358:2560; Duckworth W. NEJM 2009;360:129.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25Novartis Cardiovascular Update
with ejection fraction below normal. 5/6 HF patients covered by expanded CHF label. Post-MI. Study completed5. (see subsequent slides).
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26New Data Emphasize Prompt Initiation of ARNI Therapy as a ...
Most of the patients in the PARADIGM-HF trial were on a combination ... the PIONEER-HF trial demonstrated a reduction in NT-proBNP favoring ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27Benefits and Risks of Continuing Angiotensin-Converting ...
The evidence generated by the PARAMOUNT trial led to the Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure (PIONEER-HF) trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28Sacubitril/valsartan versus angiotensin inhibitors and ...
Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure: secondary analysis of the open-label extension of the PIONEER-HF trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Actualización Sacubitrilo/Valsartan - UNIC 2020 Home
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection ... randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30Updates in Advanced Heart Failure 2019
Top Clinical Trials in Heart Failure 2019 ... Clinical Trials: Dapa HF. McMurray et al. NEJM. Sept 19, 2019 ... Clinical Trials: Pioneer HF Trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31An updated perspective and pooled analysis of cardiovascular ...
the risk of hospitalization for heart failure independent of the ... Except PIONEER-6 trial (17), all the studies used a cut-off value.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32Impact of Sacubitril/Valsartan on Patient Outcomes in Heart ...
In February 2019, the PIONEER-HF trial (The Comparison of Sacubitril/Valsartan versus Enalapril on Effect on NT-proBNP in Patients ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33Updates on sacubitril-valsartan - ppt download - SlidePlayer
8 Clinical Trials Trial Name Date Published Patient Population PARADIGM-HF 9/11/2014 Heart Failure with Reduced Ejection (HFrEF) PIONEER-HF 11/11/2018 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#342021 ESC Guidelines for the diagnosis and treatment of acute ...
randomized trials in patients with heart failure with reduced ejection fraction . ... dations including condensed pocket guideline versions, summary slides,.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35The Lancet Publishes Results From COSMIC-HF Trial ...
The COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase ... A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36Decentralized Clinical Trials In 2020 - Pharma Intelligence
“Decentralized clinical trials are defined as those ... CHIEF-HF: Invokana real-world study ... Source: Informa Connect; NEJM Catalyst.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37Heart Failure - Video - PACE-CME
Efficacy and safety of ARNI in high-risk patients in the PIONEER-HF trial. 5' education - Dec. 19, 2019 - Prof. David Morrow, MD.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38Managing Heart Failure with Reduced Ejection Fraction in 2019
AHA Guideline for the Management of Heart Failure. Yancy CW, et al. ... PIONEER-HF ... VerICiguaT Global Study in Subjects With Heart Failure.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39A Trial Investigating the Cardiovascular Safety of Oral ...
... Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER 6) ... UAP Requiring Hospitalisation or Hospitalisation for Heart Failure [ Time ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40Sacubitril/valsartan - Wikipedia
In 2019, the PIONEER-HF and PARAGON-HF trials studied the effect of sacubitril/valsartan in 800 patients recently hospitalised with severe heart failure and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41Real-World Safety of Sacubitril/Valsartan in Women and Men ...
In patients with heart failure and preserved left ventricle ejection ... and comparable with the incidence reported in the PIONEER-HF trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#422021 ESC Guidelines on cardiovascular disease prevention in ...
(New York Heart Association class II-IV) heart failure with ... Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43Clinical Trial Results: The International Leader in Medical Media
Dr. Robert Rosenson and Dr. C. Michael Gibson Discuss: A Phase 2 Trial Of The ... Syndromes: Primary Endpoint Results of the PIONEER III Trial Slides.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44Heart Failure with Reduced EF - Iowa ACC Chapter
Section of Heart Failure and Cardiac Transplantation ... The ESCAPE trial demonstrated no significant benefit of routine ... NEJM 2018, In press.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45Paradigm Hf Nejm Study
Paradigm Shifts in Heart-Failure Therapy — A Timeline … Study. Details: With the publication of the PARADIGM-HF trial in the Journal (pages 993–1004) we may ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46L'ottimizzazione terapeutica nel percorso del paziente con ...
Velazquez EJ, Morrow DA, DeVore AD, et al.; PIONEER-HF Investigators. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med 2019; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47Sacubitril-Valsartan - Cardio Alessandria
Maggioni A et al.; European Journal of Heart Failure (2016). ... study drug (%) ... PIONEER HF è uno studio randomizzato, in doppio.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48putative placebo analysis of the effects of LCZ696 on clinical ...
AbstractAims. Although active-controlled trials with renin–angiotensin inhibitors are ethically mandated in heart failure with reduced ejection fraction, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49Comparison of the Efficacy and Safety of Sacubitril/Valsartan ...
More recently, the Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (PIONEER-HF) trial compared sacubitril/valsartan ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50Invited review. Series: Implications of the recent CVOTs in type ...
Large cardiovascular outcome trials (CVOTs) have lent support to a ... in those with evidence of heart failure and impaired kidney function, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51Supercourse Lectures in PPT/PDF Format - University of ...
39091, Concepts in Public Health: A Case Study of Diarrhea. 39101, Persistent organic pollutants and metabolic syndrome; Clinical implications.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52What Comes Next After Stabilized Acute Heart Failure?
Vulnerable Phase After HHF: Challenges. Acute HF: Goals of Treatment. Contribution of Acute Events to the Progression of HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#532021 ESC Guidelines for the diagnosis and ... - Oxford Academic
Atrial fibrillation – Congestive Heart Failure (trial) ... summary slides, summary cards for non-specialists and an electronic version for ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54Supercourse Lectures in PPT/PDF Format - UMIN
Supercourse Lectures in Power Point/pdf Format ... 41221, Concepts in Public Health: A Case Study of Protein Energy ... 9591, Diastolic Heart Failure.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55Systematic Review of Cardiovascular Outcome Trials Using ...
et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020; 383: 1413 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56ICD-10 International Statistical Classification of Diseases and ...
The categories have to be chosen to facilitate the statistical study of ... *This does not mean the mode of dying, e.g. heart failure, respiratory failure.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57Supercourse Lectures in PPT/PDF Format
41221, Concepts in Public Health: A Case Study of Protein Energy ... 32021, Not to be Forgotten, Alice Hamilton, Pioneer Occupational Epidemiologist.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58KDIGO 2020 Clinical Practice Guideline for Diabetes ...
Cardiovascular and kidney outcome trials for GLP-1 RA ... with aggressive diuretic use and low cardiac output seen in heart failure; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#59Cardiovascular impact of diabetes medications
HR, hazard ratio; CV, cardiovascular. Zinman, et al. NEJM. 2015 ... More renal and heart failure outcomes trials are underway.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60AR910.pdf - Ministry of Defence
carried out an incisive study on India's ... Phase-I of Captive flight trial from Su-30 Mk-I ... has been the pioneer in foreign language.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61Funding & tender opportunities - European Commission
The slides and the recording of the European Defence Fund Info Day are now ... The Commission published a new study funded under the European Maritime and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Renal Outcomes in Patients with Systolic Heart Failure ...
From a renal perspective, post hoc analysis of the PARADIGM-HF study reported that sacubitril-valsartan had a more favorable effect than did ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63Clinical practice update on heart failure 2019
In the PIONEER-HF trial, patients with HFrEF hospitalized for new-onset (about one third) or worsening CHF (about two thirds) were stabilized and then ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#64View of Diabetes medications with cardiovascular protection ...
PIONEER 6 was a randomised controlled trial of the oral GLP-1RA semaglutide ... DAPA-HF involved 4,744 patients with New York Heart Association class II, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65엔트레스토가 급성심부전에서도 효과를 입증하다 - 네이버 블로그
엔트레스토가 급성심부전에서도 효과를 입증하다 – PIONEER-HF trial ... Inhibition in Acute Decompensated Heart Failure | NEJM.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#662020 ESC Guidelines for the diagnosis and management of ...
11.6 Atrial fibrillation and heart failure . ... for Prevention of Stroke and Embolism Trial in. Atrial Fibrillation. SAMe-TT2R2.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#67Design, Conduct, and Analysis of Clinical Trials Course Slides
Design, Conduct, and Analysis of Clinical Trials. Course Slides ... 26 Clinical trials: Subgroup analysis vs data dredging . ... Congestive heart failure.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68Management of Antithrombotic Therapy after Acute Coronary ...
PIONEER. AF-PCI (Open-Label, Randomized, Controlled,. Multicenter Study Exploring Two Treatment. Strategies of Rivaroxaban and a Dose-Adjusted.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#696. Promoting Resilience
the medical research pioneer, Archie Cochrane, regarding the proper ... study of a large sample of not very well-off people, for whom child.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70Sacubitril/Valsartan: The Newest Addition to the Toolbox for ...
In patients with chronic New York Heart Association class II-IV heart failure with reduced ejection fraction, the PARADIGM-HF trial ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71Clinical Trial Results
Dr. John Spertus and Dr. Yazan Daaboul Discuss: CHIEF-HF: The ... of Atrial Fibrillation: A Randomized Controlled Trial View Video | Download Slides.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72Report from the 4th Cardiovascular Outcome Trial (CVOT ...
The recently presented PIONEER-HF trial revealed that valsartan/sacubitril, compared to enalapril, also has a significantly greater effect ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73Sacubitril/valsartan: A practical guide revisited - Revista ...
The TRANSITION and PIONEER-HF trials evaluated the initiation of sacubitril/valsartan in severe HFrEF patients after stabilization following an acute heart ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#74PIONEER-HF Extension: Don't stall starting sacubitril/valsartan
The clinical event gap between the two study arms documented at week 8 in the double-blind phase of the trial didn't close significantly in the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#75無題
HF Propagation prediction tool. ... Schizophrenia Case Study Pdf Oct 26, 2021 · Search: Swift Split String By Newline. ... Scion pioneer radio manual.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#76Heart Failure Management 2019
LCZ696 200 mg BID. PARADIGM-HF: Study Design. Randomization. LCZ696 http://www.clinicaltrialresults.org/Slides/ESC%202014/Packer%20-PARADIGM.ppt ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#77Venturi excel sheet. The trends in actual and ideal static ...
PPT – Simplified SBR wastewater treatment plant design. ... Weir Flow Equations Open Channel Flow over V-Notch Weir Calculations Case Study - A confidential ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#78PARAGON-HF Trial Overview - American Journal of Managed ...
An overview of the PARAGON-HF trial with special consideration to the ... Heart Failure With Preserved Ejection Fraction: Current Status and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#79Cv conference 2021. June 15, 2021. Box 400747 ...
Case Status: Pending, Jury Trial SCHEDULING CONFERENCE Civil Violations, ... link to ensure submitting the PPT/Videos to elibrary by June 17, 2021.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#80無題
A study involving a simple salt water solution which may help to reduce the ... As a nutritional visionary and health pioneer, she has fearlessly stood on ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#81Good Agricultural Practices for greenhouse vegetable crops
study, research and teaching purposes, or for use in non-commercial products or services, ... FH. Float hydroponics. FU. Functional unit. FW. Fresh weight.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#82PIONEER-HF Supports Entresto as a First Choice Systolic ...
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#83gprc5d car t bms. * The purified CD8-positive and CD4 ...
19 Jul 2021 Bristol-Myers Squibb completes a phase II trial in Decompensated heart failure in Argentina, Greece, Poland, Czech Republic, Israel and UK (SC) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#84無題
Start a trial VU. ... HF Propagation prediction tool. ... Honda Pioneer 700 Storage "Sweet/Vicious" is an offbeat superhero story for the millennial ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#85Optimizing GDMT for HFrEF During Hospitalization - US ...
Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced ... The PIONEER-HF trial suggested benefits of ARNI initiation during ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
pioneer-hf 在 コバにゃんチャンネル Youtube 的最佳解答
pioneer-hf 在 大象中醫 Youtube 的最佳貼文
pioneer-hf 在 大象中醫 Youtube 的最讚貼文